Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women

scientific article (publication date: 2013)

Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PNTD.0002346
P3181OpenCitations bibliographic resource ID1902470
P932PMC publication ID3731236
P698PubMed publication ID23936578
P5875ResearchGate publication ID255737754

P50authorJeffrey P. TownsendQ51706465
Lauren Ancel MeyersQ51905789
Evan W OrensteinQ57059932
Alison P. GalvaniQ21594962
P2093author name stringKatherine E Atkins
Eric M Poolman
Martial L Ndeffo Mbah
P2860cites workAcquired immunity and epidemiology of Schistosoma haematobium.Q52447698
Economic evaluations of adult male circumcision for prevention of heterosexual acquisition of HIV in men in sub-Saharan Africa: a systematic reviewQ21091142
Africa's 32 cents solution for HIV/AIDSQ21092298
Examining the relationship between urogenital schistosomiasis and HIV infectionQ24290707
Disease transmission models for public health decision making: toward an approach for designing intervention strategies for Schistosomiasis japonicaQ24810668
Association between genital schistosomiasis and HIV in rural Zimbabwean womenQ28296559
Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studiesQ28307869
National mass drug administration costs for lymphatic filariasis eliminationQ28469337
Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic reviewQ28477145
Quantification of clinical morbidity associated with schistosome infection in sub-Saharan AfricaQ29620602
Cost-effectiveness of male circumcision for HIV prevention in a South African settingQ33267835
When did HIV incidence peak in Harare, Zimbabwe? Back-calculation from mortality statisticsQ33322515
HIV Spending as a Share of Total Health Expenditure: An Analysis of Regional Variation in a Multi-Country StudyQ33707565
The incidence of HIV among women recruited during late pregnancy and followed up for six years after childbirth in ZimbabweQ33737117
Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to data from ZimbabweQ33830261
Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couplesQ34030252
Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countriesQ34227577
Female genital schistosomiasis: facts and hypothesesQ34285974
Urogenital schistosomiasis in women of reproductive age in Tanzania's Lake Victoria regionQ34592127
Factors affecting infection or reinfection with Schistosoma haematobium in coastal Kenya: survival analysis during a nine-year, school-based treatment program.Q36165311
Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in AfricaQ36835774
A review of female genital schistosomiasis.Q37975833
Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, UgandaQ38881798
Female genital schistosomiasis as a risk-factor for the transmission of HIV.Q38889336
Integrating neglected tropical diseases into AIDS, tuberculosis, and malaria controlQ39078342
Prevention of gynecologic contact bleeding and genital sandy patches by childhood anti-schistosomal treatment.Q39140054
Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean womenQ39140070
Reversibility of lower reproductive tract abnormalities in women with Schistosoma haematobium infection after treatment with praziquantel--an interim report.Q39397558
The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries.Q40353327
Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in northern TanzaniaQ43951838
The cost of delivering and sustaining a control programme for schistosomiasis and soil-transmitted helminthiasisQ44439782
Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in ZimbabweQ46178331
Long-term suppression of adult bladder morbidity and severe hydronephrosis following selective population chemotherapy for Schistosoma haematobiumQ46492490
Sexual mixing patterns of patients attending sexually transmitted diseases clinics.Q51020809
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectZimbabweQ954
infectious diseaseQ18123741
schistosomiasisQ221159
cost-effectiveness analysisQ1754768
HIV transmissionQ49029021
P304page(s)e2346
P577publication date2013-01-01
P1433published inPLoS Neglected Tropical DiseasesQ3359737
P1476titlePotential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women
P478volume7

Reverse relations

cites work (P2860)
Q92162777A primer on multiscale modelling of infectious disease systems
Q92714202Cost-effectiveness of HIV Prevention Interventions in Sub-Saharan Africa: A Systematic Review
Q28072167Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review
Q35048242Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities
Q64077656Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women
Q91673318Impact of Endemic Infections on HIV Susceptibility in Sub-Saharan Africa
Q28543825Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa
Q36834713Morphological Characteristics of Schistosoma mansoni PZQ-Resistant and -Susceptible Strains Are Different in Presence of Praziquantel
Q38223613Neglected tropical diseases: now more than just 'other diseases'--the post-2015 agenda
Q34705514Schistosome ABC multidrug transporters: From pharmacology to physiology
Q91591248Schistosome TRP channels: An appraisal
Q64252322Schistosomiasis in School Age Children in Sierra Leone After 6 Years of Mass Drug Administration With Praziquantel
Q64901248TRP channels as potential targets for antischistosomals.
Q26738732TRP channels in schistosomes
Q28551751The Accuracy of Praziquantel Dose Poles for Mass Treatment of Schistosomiasis in School Girls in KwaZulu-Natal, South Africa
Q91721744The impact of vector migration on the effectiveness of strategies to control gambiense human African trypanosomiasis

Search more.